ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
Ned E. Bibler
Nuclear Technology | Volume 34 | Number 3 | August 1977 | Pages 412-415
Technical Paper | Chemical Processing | doi.org/10.13182/NT77-A31805
Articles are hosted by Taylor and Francis Online.
The radiolytic oxidation of Fe(II) and the destruction of sulfamic acid (SA) in feed solutions for solvent extraction purification of 237Np and 238Pu from spent nuclear fuels have been investigated. Cobalt-60 gamma radiolysis of simulated solutions established that 100-eV yields for depletion of Fe(II) and SA are 13 and 5.6, respectively. Also, the normally occurring components of process solutions do not significantly affect these yields. An actual process solution was studied in which radiolysis was almost entirely from gamma-ray and beta-particle decay of 235U fission products along with a small fraction from alpha-particle decay of transuranium isotopes. In this solution, G(Fe3+) is 12, which is in good agreement with results with simulated solutions. Interpretation of the results suggests that Fe(II) not only reduces Np(V) and Pu(IV) but also protects the reduced states from reoxidation by radiolytically formed intermediates; when Fe(II) is depleted, the reduced states are immediately oxidized.